Summary
Clinical Research Organization (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form of outsourced pharmaceutical research services. Full-Service Clinical Research Organization offer a full range of services covering drug development from start to finish. Full-Service Clinical Research Organization offer all the services of regulatory affairs, site selection and activation, site management, monitoring, data management, logistics management, pharmacovigilance, biostatistics, medical writing, and project management.
According to APO Research, The global Full-Service Clinical Research Organization (CRO) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Full-Service Clinical Research Organization (CRO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Full-Service Clinical Research Organization (CRO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Full-Service Clinical Research Organization (CRO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Full-Service Clinical Research Organization (CRO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Full-Service Clinical Research Organization (CRO) include IQVIA, Labcorp, Syneos Health, PPD, ICON, PRA, Parexel, Medpace and Wuxi Apptec, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Full-Service Clinical Research Organization (CRO), market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Full-Service Clinical Research Organization (CRO), also provides the revenue of main regions and countries. Of the upcoming market potential for Full-Service Clinical Research Organization (CRO), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Full-Service Clinical Research Organization (CRO) revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Full-Service Clinical Research Organization (CRO) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Full-Service Clinical Research Organization (CRO) revenue, projected growth trends, production technology, application and end-user industry.
Full-Service Clinical Research Organization (CRO) segment by Company
IQVIA
Labcorp
Syneos Health
PPD
ICON
PRA
Parexel
Medpace
Wuxi Apptec
EPS International
Worldwide Clinical Trials
CMIC
Premier Research
Courante Oncology
PROMETRIKA
Full-Service Clinical Research Organization (CRO) segment by Type
Clinical CRO
Preclinical CRO
Full-Service Clinical Research Organization (CRO) segment by End Use
Small Medium Enterprise
Large Enterprise
Full-Service Clinical Research Organization (CRO) segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Full-Service Clinical Research Organization (CRO) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Full-Service Clinical Research Organization (CRO) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Full-Service Clinical Research Organization (CRO).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Full-Service Clinical Research Organization (CRO) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Full-Service Clinical Research Organization (CRO) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Full-Service Clinical Research Organization (CRO) revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Full-Service Clinical Research Organization (CRO) Market by Type
1.2.1 Global Full-Service Clinical Research Organization (CRO) Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Clinical CRO
1.2.3 Preclinical CRO
1.3 Full-Service Clinical Research Organization (CRO) Market by End Use
1.3.1 Global Full-Service Clinical Research Organization (CRO) Market Size by End Use, 2019 VS 2023 VS 2030
1.3.2 Small Medium Enterprise
1.3.3 Large Enterprise
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Full-Service Clinical Research Organization (CRO) Market Dynamics
2.1 Full-Service Clinical Research Organization (CRO) Industry Trends
2.2 Full-Service Clinical Research Organization (CRO) Industry Drivers
2.3 Full-Service Clinical Research Organization (CRO) Industry Opportunities and Challenges
2.4 Full-Service Clinical Research Organization (CRO) Industry Restraints
3 Global Growth Perspective
3.1 Global Full-Service Clinical Research Organization (CRO) Market Perspective (2019-2030)
3.2 Global Full-Service Clinical Research Organization (CRO) Growth Trends by Region
3.2.1 Global Full-Service Clinical Research Organization (CRO) Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Full-Service Clinical Research Organization (CRO) Market Size by Region (2019-2024)
3.2.3 Global Full-Service Clinical Research Organization (CRO) Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Full-Service Clinical Research Organization (CRO) Revenue by Players
4.1.1 Global Full-Service Clinical Research Organization (CRO) Revenue by Players (2019-2024)
4.1.2 Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by Players (2019-2024)
4.1.3 Global Full-Service Clinical Research Organization (CRO) Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Full-Service Clinical Research Organization (CRO) Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Full-Service Clinical Research Organization (CRO) Key Players Headquarters & Area Served
4.4 Global Full-Service Clinical Research Organization (CRO) Players, Product Type & Application
4.5 Global Full-Service Clinical Research Organization (CRO) Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Full-Service Clinical Research Organization (CRO) Market CR5 and HHI
4.6.2 Global Top 5 and 10 Full-Service Clinical Research Organization (CRO) Players Market Share by Revenue in 2023
4.6.3 2023 Full-Service Clinical Research Organization (CRO) Tier 1, Tier 2, and Tier 3
5 Full-Service Clinical Research Organization (CRO) Market Size by Type
5.1 Global Full-Service Clinical Research Organization (CRO) Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Full-Service Clinical Research Organization (CRO) Revenue by Type (2019-2030)
5.3 Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by Type (2019-2030)
6 Full-Service Clinical Research Organization (CRO) Market Size by Application
6.1 Global Full-Service Clinical Research Organization (CRO) Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Full-Service Clinical Research Organization (CRO) Revenue by Application (2019-2030)
6.3 Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 IQVIA
7.1.1 IQVIA Comapny Information
7.1.2 IQVIA Business Overview
7.1.3 IQVIA Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2019-2024)
7.1.4 IQVIA Full-Service Clinical Research Organization (CRO) Product Portfolio
7.1.5 IQVIA Recent Developments
7.2 Labcorp
7.2.1 Labcorp Comapny Information
7.2.2 Labcorp Business Overview
7.2.3 Labcorp Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2019-2024)
7.2.4 Labcorp Full-Service Clinical Research Organization (CRO) Product Portfolio
7.2.5 Labcorp Recent Developments
7.3 Syneos Health
7.3.1 Syneos Health Comapny Information
7.3.2 Syneos Health Business Overview
7.3.3 Syneos Health Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2019-2024)
7.3.4 Syneos Health Full-Service Clinical Research Organization (CRO) Product Portfolio
7.3.5 Syneos Health Recent Developments
7.4 PPD
7.4.1 PPD Comapny Information
7.4.2 PPD Business Overview
7.4.3 PPD Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2019-2024)
7.4.4 PPD Full-Service Clinical Research Organization (CRO) Product Portfolio
7.4.5 PPD Recent Developments
7.5 ICON
7.5.1 ICON Comapny Information
7.5.2 ICON Business Overview
7.5.3 ICON Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2019-2024)
7.5.4 ICON Full-Service Clinical Research Organization (CRO) Product Portfolio
7.5.5 ICON Recent Developments
7.6 PRA
7.6.1 PRA Comapny Information
7.6.2 PRA Business Overview
7.6.3 PRA Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2019-2024)
7.6.4 PRA Full-Service Clinical Research Organization (CRO) Product Portfolio
7.6.5 PRA Recent Developments
7.7 Parexel
7.7.1 Parexel Comapny Information
7.7.2 Parexel Business Overview
7.7.3 Parexel Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2019-2024)
7.7.4 Parexel Full-Service Clinical Research Organization (CRO) Product Portfolio
7.7.5 Parexel Recent Developments
7.8 Medpace
7.8.1 Medpace Comapny Information
7.8.2 Medpace Business Overview
7.8.3 Medpace Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2019-2024)
7.8.4 Medpace Full-Service Clinical Research Organization (CRO) Product Portfolio
7.8.5 Medpace Recent Developments
7.9 Wuxi Apptec
7.9.1 Wuxi Apptec Comapny Information
7.9.2 Wuxi Apptec Business Overview
7.9.3 Wuxi Apptec Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2019-2024)
7.9.4 Wuxi Apptec Full-Service Clinical Research Organization (CRO) Product Portfolio
7.9.5 Wuxi Apptec Recent Developments
7.10 EPS International
7.10.1 EPS International Comapny Information
7.10.2 EPS International Business Overview
7.10.3 EPS International Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2019-2024)
7.10.4 EPS International Full-Service Clinical Research Organization (CRO) Product Portfolio
7.10.5 EPS International Recent Developments
7.11 Worldwide Clinical Trials
7.11.1 Worldwide Clinical Trials Comapny Information
7.11.2 Worldwide Clinical Trials Business Overview
7.11.3 Worldwide Clinical Trials Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2019-2024)
7.11.4 Worldwide Clinical Trials Full-Service Clinical Research Organization (CRO) Product Portfolio
7.11.5 Worldwide Clinical Trials Recent Developments
7.12 CMIC
7.12.1 CMIC Comapny Information
7.12.2 CMIC Business Overview
7.12.3 CMIC Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2019-2024)
7.12.4 CMIC Full-Service Clinical Research Organization (CRO) Product Portfolio
7.12.5 CMIC Recent Developments
7.13 Premier Research
7.13.1 Premier Research Comapny Information
7.13.2 Premier Research Business Overview
7.13.3 Premier Research Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2019-2024)
7.13.4 Premier Research Full-Service Clinical Research Organization (CRO) Product Portfolio
7.13.5 Premier Research Recent Developments
7.14 Courante Oncology
7.14.1 Courante Oncology Comapny Information
7.14.2 Courante Oncology Business Overview
7.14.3 Courante Oncology Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2019-2024)
7.14.4 Courante Oncology Full-Service Clinical Research Organization (CRO) Product Portfolio
7.14.5 Courante Oncology Recent Developments
7.15 PROMETRIKA
7.15.1 PROMETRIKA Comapny Information
7.15.2 PROMETRIKA Business Overview
7.15.3 PROMETRIKA Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2019-2024)
7.15.4 PROMETRIKA Full-Service Clinical Research Organization (CRO) Product Portfolio
7.15.5 PROMETRIKA Recent Developments
8 North America
8.1 North America Full-Service Clinical Research Organization (CRO) Revenue (2019-2030)
8.2 North America Full-Service Clinical Research Organization (CRO) Revenue by Type (2019-2030)
8.2.1 North America Full-Service Clinical Research Organization (CRO) Revenue by Type (2019-2024)
8.2.2 North America Full-Service Clinical Research Organization (CRO) Revenue by Type (2025-2030)
8.3 North America Full-Service Clinical Research Organization (CRO) Revenue Share by Type (2019-2030)
8.4 North America Full-Service Clinical Research Organization (CRO) Revenue by End Use (2019-2030)
8.4.1 North America Full-Service Clinical Research Organization (CRO) Revenue by End Use (2019-2024)
8.4.2 North America Full-Service Clinical Research Organization (CRO) Revenue by End Use (2025-2030)
8.5 North America Full-Service Clinical Research Organization (CRO) Revenue Share by End Use (2019-2030)
8.6 North America Full-Service Clinical Research Organization (CRO) Revenue by Country
8.6.1 North America Full-Service Clinical Research Organization (CRO) Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Full-Service Clinical Research Organization (CRO) Revenue by Country (2019-2024)
8.6.3 North America Full-Service Clinical Research Organization (CRO) Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Full-Service Clinical Research Organization (CRO) Revenue (2019-2030)
9.2 Europe Full-Service Clinical Research Organization (CRO) Revenue by Type (2019-2030)
9.2.1 Europe Full-Service Clinical Research Organization (CRO) Revenue by Type (2019-2024)
9.2.2 Europe Full-Service Clinical Research Organization (CRO) Revenue by Type (2025-2030)
9.3 Europe Full-Service Clinical Research Organization (CRO) Revenue Share by Type (2019-2030)
9.4 Europe Full-Service Clinical Research Organization (CRO) Revenue by End Use (2019-2030)
9.4.1 Europe Full-Service Clinical Research Organization (CRO) Revenue by End Use (2019-2024)
9.4.2 Europe Full-Service Clinical Research Organization (CRO) Revenue by End Use (2025-2030)
9.5 Europe Full-Service Clinical Research Organization (CRO) Revenue Share by End Use (2019-2030)
9.6 Europe Full-Service Clinical Research Organization (CRO) Revenue by Country
9.6.1 Europe Full-Service Clinical Research Organization (CRO) Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Full-Service Clinical Research Organization (CRO) Revenue by Country (2019-2024)
9.6.3 Europe Full-Service Clinical Research Organization (CRO) Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Full-Service Clinical Research Organization (CRO) Revenue (2019-2030)
10.2 China Full-Service Clinical Research Organization (CRO) Revenue by Type (2019-2030)
10.2.1 China Full-Service Clinical Research Organization (CRO) Revenue by Type (2019-2024)
10.2.2 China Full-Service Clinical Research Organization (CRO) Revenue by Type (2025-2030)
10.3 China Full-Service Clinical Research Organization (CRO) Revenue Share by Type (2019-2030)
10.4 China Full-Service Clinical Research Organization (CRO) Revenue by End Use (2019-2030)
10.4.1 China Full-Service Clinical Research Organization (CRO) Revenue by End Use (2019-2024)
10.4.2 China Full-Service Clinical Research Organization (CRO) Revenue by End Use (2025-2030)
10.5 China Full-Service Clinical Research Organization (CRO) Revenue Share by End Use (2019-2030)
11 Asia (Excluding China)
11.1 Asia Full-Service Clinical Research Organization (CRO) Revenue (2019-2030)
11.2 Asia Full-Service Clinical Research Organization (CRO) Revenue by Type (2019-2030)
11.2.1 Asia Full-Service Clinical Research Organization (CRO) Revenue by Type (2019-2024)
11.2.2 Asia Full-Service Clinical Research Organization (CRO) Revenue by Type (2025-2030)
11.3 Asia Full-Service Clinical Research Organization (CRO) Revenue Share by Type (2019-2030)
11.4 Asia Full-Service Clinical Research Organization (CRO) Revenue by End Use (2019-2030)
11.4.1 Asia Full-Service Clinical Research Organization (CRO) Revenue by End Use (2019-2024)
11.4.2 Asia Full-Service Clinical Research Organization (CRO) Revenue by End Use (2025-2030)
11.5 Asia Full-Service Clinical Research Organization (CRO) Revenue Share by End Use (2019-2030)
11.6 Asia Full-Service Clinical Research Organization (CRO) Revenue by Country
11.6.1 Asia Full-Service Clinical Research Organization (CRO) Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Full-Service Clinical Research Organization (CRO) Revenue by Country (2019-2024)
11.6.3 Asia Full-Service Clinical Research Organization (CRO) Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Full-Service Clinical Research Organization (CRO) Revenue (2019-2030)
12.2 MEALA Full-Service Clinical Research Organization (CRO) Revenue by Type (2019-2030)
12.2.1 MEALA Full-Service Clinical Research Organization (CRO) Revenue by Type (2019-2024)
12.2.2 MEALA Full-Service Clinical Research Organization (CRO) Revenue by Type (2025-2030)
12.3 MEALA Full-Service Clinical Research Organization (CRO) Revenue Share by Type (2019-2030)
12.4 MEALA Full-Service Clinical Research Organization (CRO) Revenue by End Use (2019-2030)
12.4.1 MEALA Full-Service Clinical Research Organization (CRO) Revenue by End Use (2019-2024)
12.4.2 MEALA Full-Service Clinical Research Organization (CRO) Revenue by End Use (2025-2030)
12.5 MEALA Full-Service Clinical Research Organization (CRO) Revenue Share by End Use (2019-2030)
12.6 MEALA Full-Service Clinical Research Organization (CRO) Revenue by Country
12.6.1 MEALA Full-Service Clinical Research Organization (CRO) Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Full-Service Clinical Research Organization (CRO) Revenue by Country (2019-2024)
12.6.3 MEALA Full-Service Clinical Research Organization (CRO) Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Full-Service Clinical Research Organization (CRO) Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Clinical CRO Major Manufacturers
Table 2. Preclinical CRO Major Manufacturers
Table 3. Global Full-Service Clinical Research Organization (CRO) Market Size Growth Rate by End Use (US$ Million), 2019 VS 2023 VS 2030
Table 4. Small Medium Enterprise Major Manufacturers
Table 5. Large Enterprise Major Manufacturers
Table 6. Full-Service Clinical Research Organization (CRO) Industry Trends
Table 7. Full-Service Clinical Research Organization (CRO) Industry Drivers
Table 8. Full-Service Clinical Research Organization (CRO) Industry Opportunities and Challenges
Table 9. Full-Service Clinical Research Organization (CRO) Industry Restraints
Table 10. Global Full-Service Clinical Research Organization (CRO) Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Full-Service Clinical Research Organization (CRO) Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Full-Service Clinical Research Organization (CRO) Market Share by Region (2019-2024)
Table 13. Global Full-Service Clinical Research Organization (CRO) Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Full-Service Clinical Research Organization (CRO) Market Share by Region (2025-2030)
Table 15. Global Full-Service Clinical Research Organization (CRO) Revenue by Players (US$ Million) & (2019-2024)
Table 16. Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by Players (2019-2024)
Table 17. Global Full-Service Clinical Research Organization (CRO) Key Players Ranking, 2022 VS 2023 VS 2024
Table 18. Global Full-Service Clinical Research Organization (CRO) Key Players Headquarters & Area Served
Table 19. Global Full-Service Clinical Research Organization (CRO) Players, Product Type & Application
Table 20. Global Full-Service Clinical Research Organization (CRO) Players Commercialization Time
Table 21. Global Players Market Concentration Ratio (CR5 and HHI)
Table 22. Global Full-Service Clinical Research Organization (CRO) by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 23. Global Full-Service Clinical Research Organization (CRO) Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Full-Service Clinical Research Organization (CRO) Revenue by Type (2019-2024) & (US$ Million)
Table 25. Global Full-Service Clinical Research Organization (CRO) Revenue by Type (2025-2030) & (US$ Million)
Table 26. Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 27. Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 28. Global Full-Service Clinical Research Organization (CRO) Revenue by End Use 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Full-Service Clinical Research Organization (CRO) Revenue by End Use (2019-2024) & (US$ Million)
Table 30. Global Full-Service Clinical Research Organization (CRO) Revenue by End Use (2025-2030) & (US$ Million)
Table 31. Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by End Use (2019-2024) & (US$ Million)
Table 32. Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by End Use (2025-2030) & (US$ Million)
Table 33. IQVIA Company Information
Table 34. IQVIA Business Overview
Table 35. IQVIA Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 36. IQVIA Full-Service Clinical Research Organization (CRO) Product Portfolio
Table 37. IQVIA Recent Development
Table 38. Labcorp Company Information
Table 39. Labcorp Business Overview
Table 40. Labcorp Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 41. Labcorp Full-Service Clinical Research Organization (CRO) Product Portfolio
Table 42. Labcorp Recent Development
Table 43. Syneos Health Company Information
Table 44. Syneos Health Business Overview
Table 45. Syneos Health Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 46. Syneos Health Full-Service Clinical Research Organization (CRO) Product Portfolio
Table 47. Syneos Health Recent Development
Table 48. PPD Company Information
Table 49. PPD Business Overview
Table 50. PPD Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 51. PPD Full-Service Clinical Research Organization (CRO) Product Portfolio
Table 52. PPD Recent Development
Table 53. ICON Company Information
Table 54. ICON Business Overview
Table 55. ICON Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 56. ICON Full-Service Clinical Research Organization (CRO) Product Portfolio
Table 57. ICON Recent Development
Table 58. PRA Company Information
Table 59. PRA Business Overview
Table 60. PRA Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 61. PRA Full-Service Clinical Research Organization (CRO) Product Portfolio
Table 62. PRA Recent Development
Table 63. Parexel Company Information
Table 64. Parexel Business Overview
Table 65. Parexel Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 66. Parexel Full-Service Clinical Research Organization (CRO) Product Portfolio
Table 67. Parexel Recent Development
Table 68. Medpace Company Information
Table 69. Medpace Business Overview
Table 70. Medpace Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 71. Medpace Full-Service Clinical Research Organization (CRO) Product Portfolio
Table 72. Medpace Recent Development
Table 73. Wuxi Apptec Company Information
Table 74. Wuxi Apptec Business Overview
Table 75. Wuxi Apptec Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 76. Wuxi Apptec Full-Service Clinical Research Organization (CRO) Product Portfolio
Table 77. Wuxi Apptec Recent Development
Table 78. EPS International Company Information
Table 79. EPS International Business Overview
Table 80. EPS International Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 81. EPS International Full-Service Clinical Research Organization (CRO) Product Portfolio
Table 82. EPS International Recent Development
Table 83. Worldwide Clinical Trials Company Information
Table 84. Worldwide Clinical Trials Business Overview
Table 85. Worldwide Clinical Trials Full-Service Clinical Research Organization (CRO) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 86. Worldwide Clinical Trials Full-Service Clinical Research Organization (CRO) Product Portfolio
Table 87. Worldwide Clinical Trials Recent Development
Table 88. CMIC Company Information
Table 89. CMIC Business Overview
Table 90. CMIC Full-Service Clinical Research Organization (CRO) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 91. CMIC Full-Service Clinical Research Organization (CRO) Product Portfolio
Table 92. CMIC Recent Development
Table 93. Premier Research Company Information
Table 94. Premier Research Business Overview
Table 95. Premier Research Full-Service Clinical Research Organization (CRO) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 96. Premier Research Full-Service Clinical Research Organization (CRO) Product Portfolio
Table 97. Premier Research Recent Development
Table 98. Courante Oncology Company Information
Table 99. Courante Oncology Business Overview
Table 100. Courante Oncology Full-Service Clinical Research Organization (CRO) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 101. Courante Oncology Full-Service Clinical Research Organization (CRO) Product Portfolio
Table 102. Courante Oncology Recent Development
Table 103. PROMETRIKA Company Information
Table 104. PROMETRIKA Business Overview
Table 105. PROMETRIKA Full-Service Clinical Research Organization (CRO) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 106. PROMETRIKA Full-Service Clinical Research Organization (CRO) Product Portfolio
Table 107. PROMETRIKA Recent Development
Table 108. North America Full-Service Clinical Research Organization (CRO) Revenue by Type (2019-2024) & (US$ Million)
Table 109. North America Full-Service Clinical Research Organization (CRO) Revenue by End Use (2019-2024) & (US$ Million)
Table 110. North America Full-Service Clinical Research Organization (CRO) Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 111. North America Full-Service Clinical Research Organization (CRO) Revenue by Country (2019-2024) & (US$ Million)
Table 112. North America Full-Service Clinical Research Organization (CRO) Revenue by Country (2025-2030) & (US$ Million)
Table 113. Europe Full-Service Clinical Research Organization (CRO) Revenue by Type (2019-2024) & (US$ Million)
Table 114. Europe Full-Service Clinical Research Organization (CRO) Revenue by End Use (2019-2024) & (US$ Million)
Table 115. Europe Full-Service Clinical Research Organization (CRO) Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 116. Europe Full-Service Clinical Research Organization (CRO) Revenue by Country (2019-2024) & (US$ Million)
Table 117. Europe Full-Service Clinical Research Organization (CRO) Revenue by Country (2025-2030) & (US$ Million)
Table 118. China Full-Service Clinical Research Organization (CRO) Revenue by Type (2019-2024) & (US$ Million)
Table 119. China Full-Service Clinical Research Organization (CRO) Revenue by End Use (2019-2024) & (US$ Million)
Table 120. Asia Full-Service Clinical Research Organization (CRO) Revenue by Type (2019-2024) & (US$ Million)
Table 121. Asia Full-Service Clinical Research Organization (CRO) Revenue by End Use (2019-2024) & (US$ Million)
Table 122. Asia Full-Service Clinical Research Organization (CRO) Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 123. Asia Full-Service Clinical Research Organization (CRO) Revenue by Country (2019-2024) & (US$ Million)
Table 124. Asia Full-Service Clinical Research Organization (CRO) Revenue by Country (2025-2030) & (US$ Million)
Table 125. MEALA Full-Service Clinical Research Organization (CRO) Revenue by Type (2019-2024) & (US$ Million)
Table 126. MEALA Full-Service Clinical Research Organization (CRO) Revenue by End Use (2019-2024) & (US$ Million)
Table 127. MEALA Full-Service Clinical Research Organization (CRO) Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 128. MEALA Full-Service Clinical Research Organization (CRO) Revenue by Country (2019-2024) & (US$ Million)
Table 129. MEALA Full-Service Clinical Research Organization (CRO) Revenue by Country (2025-2030) & (US$ Million)
Table 130. Research Programs/Design for This Report
Table 131. Authors List of This Report
Table 132. Secondary Sources
Table 133. Primary Sources
List of Figures
Figure 1. Full-Service Clinical Research Organization (CRO) Product Picture
Figure 2. Global Full-Service Clinical Research Organization (CRO) Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Full-Service Clinical Research Organization (CRO) Market Size Share 2019 VS 2023 VS 2030
Figure 4. Clinical CRO Picture
Figure 5. Preclinical CRO Picture
Figure 6. Global Full-Service Clinical Research Organization (CRO) Market Size Growth Rate by End Use (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Full-Service Clinical Research Organization (CRO) Market Size Share 2019 VS 2023 VS 2030
Figure 8. Small Medium Enterprise Picture
Figure 9. Large Enterprise Picture
Figure 10. Global Full-Service Clinical Research Organization (CRO) Market Size (US$ Million) & (2019-2030)
Figure 11. Global Full-Service Clinical Research Organization (CRO) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Full-Service Clinical Research Organization (CRO) Market Share by Region: 2019 VS 2023 VS 2030
Figure 13. Global Full-Service Clinical Research Organization (CRO) Players Revenue Share Top 10 and Top 5 in 2023
Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 15. Global Full-Service Clinical Research Organization (CRO) Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Full-Service Clinical Research Organization (CRO) Revenue Market Share 2019 VS 2023 VS 2030
Figure 17. Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by Type (2019-2030)
Figure 18. Global Full-Service Clinical Research Organization (CRO) Revenue by End Use (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by End Use (2019 VS 2023 VS 2030)
Figure 20. Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by End Use (2019-2030)
Figure 21. North America Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Full-Service Clinical Research Organization (CRO) Revenue by Type (2025-2030) & (US$ Million)
Figure 23. North America Full-Service Clinical Research Organization (CRO) Revenue Share by Type (2019-2030)
Figure 24. North America Full-Service Clinical Research Organization (CRO) Revenue by Application (2025-2030) & (US$ Million)
Figure 25. North America Full-Service Clinical Research Organization (CRO) Revenue Share by Application (2019-2030)
Figure 26. North America Full-Service Clinical Research Organization (CRO) Revenue Share by Country (2019-2030)
Figure 27. United States Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 28. Canada Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 29. Europe Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 30. Europe Full-Service Clinical Research Organization (CRO) Revenue by Type (2025-2030) & (US$ Million)
Figure 31. Europe Full-Service Clinical Research Organization (CRO) Revenue Share by Type (2019-2030)
Figure 32. Europe Full-Service Clinical Research Organization (CRO) Revenue by Application (2025-2030) & (US$ Million)
Figure 33. Europe Full-Service Clinical Research Organization (CRO) Revenue Share by Application (2019-2030)
Figure 34. Europe Full-Service Clinical Research Organization (CRO) Revenue Share by Country (2019-2030)
Figure 35. Germany Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 36. France Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 37. U.K. Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 38. Italy Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. Russia Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. Nordic Countries Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. China Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 42. China Full-Service Clinical Research Organization (CRO) Revenue by Type (2025-2030) & (US$ Million)
Figure 43. China Full-Service Clinical Research Organization (CRO) Revenue Share by Type (2019-2030)
Figure 44. China Full-Service Clinical Research Organization (CRO) Revenue by Application (2025-2030) & (US$ Million)
Figure 45. China Full-Service Clinical Research Organization (CRO) Revenue Share by Application (2019-2030)
Figure 46. Asia Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 47. Asia Full-Service Clinical Research Organization (CRO) Revenue by Type (2025-2030) & (US$ Million)
Figure 48. Asia Full-Service Clinical Research Organization (CRO) Revenue Share by Type (2019-2030)
Figure 49. Asia Full-Service Clinical Research Organization (CRO) Revenue by Application (2025-2030) & (US$ Million)
Figure 50. Asia Full-Service Clinical Research Organization (CRO) Revenue Share by Application (2019-2030)
Figure 51. Asia Full-Service Clinical Research Organization (CRO) Revenue Share by Country (2019-2030)
Figure 52. Japan Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 53. South Korea Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 54. India Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 55. Australia Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. China Taiwan Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. Southeast Asia Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. MEALA Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 59. MEALA Full-Service Clinical Research Organization (CRO) Revenue by Type (2025-2030) & (US$ Million)
Figure 60. MEALA Full-Service Clinical Research Organization (CRO) Revenue Share by Type (2019-2030)
Figure 61. MEALA Full-Service Clinical Research Organization (CRO) Revenue by Application (2025-2030) & (US$ Million)
Figure 62. MEALA Full-Service Clinical Research Organization (CRO) Revenue Share by Application (2019-2030)
Figure 63. MEALA Full-Service Clinical Research Organization (CRO) Revenue Share by Country (2019-2030)
Figure 64. Mexico Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 65. South Korea Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 66. Brazil Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 67. Israel Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. Argentina Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Colombia Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Turkey Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Saudi Arabia Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. UAE Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Years Considered
Figure 74. Research Process
Figure 75. Key Executives Interviewed
